Dr. Marc J. Schweiger, MD

Dr. Schweiger practices at Baystate Medical Center in Springfield, Massachusetts, part of Baystate Health.

Dr. Schweiger's NPI, 1467550145, was assigned on September 20, 2006. Dr. Schweiger holds Massachusetts license 79077.

Dr. Schweiger's primary practice is Baystate Medical Center, at 759 Chestnut Street, Springfield, MA 01199 in Hampden County. The practice phone is (413) 794-0000.

Dr. Schweiger's primary practice is Baystate Medical Center in Springfield, Massachusetts, part of Baystate Health. Dr. Schweiger is also affiliated with Baystate Noble Hospital. The medical group on file is Baystate Medical Practices. Dmand AI also links Dr. Schweiger to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schweiger practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Schweiger's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Schweiger is licensed in Massachusetts.

CMS data shows 39 Medicare services from Dr. Schweiger across 2 procedure codes in 2024, all of them office visits, for 43 Medicare patients. Medicare paid $5,922 for them. Every service was in an office.

CMS counts 43 Medicare patients who saw Dr. Schweiger in 2024. The largest group is 65 to 74, with 15 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schweiger's median patient age at 70, with 31% women.

In 2024, Dr. Schweiger wrote 42 Medicare Part D claims for 13 patients. 79% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $176 in total drug cost. In 2022, CMS named 22 claims across 2 drugs.

Dr. Schweiger accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Dr. Schweiger, published from 2011 to 2021. The most frequent topics are Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors and Eptifibatide. Dr. Schweiger's most frequent co-authors are Gregory R. Giugliano, MD, Amir S. Lotfi, MD and James R. Cook, MD.

CMS Open Payments shows 11 general payments to Dr. Schweiger from 8 drug and device companies from 2019 to 2022. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $92.